PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
02-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
02-May-2025 ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 ProQR
01-May-2025 First patient enrolled in Phase 1 clinical trial of Akiram’s cancer drug candidate AKIR001 Akiram Therapeutics
01-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
01-May-2025 NICE recommends Yselty®▼ (linzagolix) for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis[i] Theramex
30-Apr-2025 BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47) BlackfinBio
30-Apr-2025 CellProthera to Present ProtheraCytes® Clinical Data and Receive a Stem Cell Engineering Abstract Award for Phase I/IIb Results at ISCT 2025 Scientific Annual Meeting in New Orleans CellProthera
30-Apr-2025 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy CSL Vifor and Travere Therapeutics
30-Apr-2025 Cycuria Therapeutics Launches with the Formation of a Distinguished Advisory Board and Significant Public Grant Funding Cycuria Therapeutics
30-Apr-2025 Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC Johnson & Johnson’s
30-Apr-2025 Novo Nordisk Foundation expands Challenge Programme outside of Denmark for the first time and significantly increases grants Novo Nordisk
30-Apr-2025 OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain OKYO Pharma
30-Apr-2025 Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France Olon Group
30-Apr-2025 EVERSANA Strengthens Position as a Leading 3PL & Channel Provider with New 358,000 Square Foot Distribution Center, Expanded Cold Chain Capabilities, Enhanced Warehouse Management System and AI-Powered Robotics EVERSANA
30-Apr-2025 IFS Maven Equity Finance and the Scottish National Investment Bank back NCIMB with £1.7 million investment to drive growth NCIMB Limited
30-Apr-2025 PureTech Announces Annual Results for Year Ended December 31, 2024 PureTech Health plc
30-Apr-2025 RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA® RetinAI and FVS
30-Apr-2025 UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine Stablepharma Ltd
30-Apr-2025 Vapourtec video showcases fully automated peptide synthesis Vapourtec
30-Apr-2025 Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers Veranova